Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial

Jules A. A. C. Heuberger*, Joris I. Rotmans, Pim Gal, Frederik E. Stuurman, Juliette van 't Westende, Titiaan E. Post, Johannes M. A. Daniels, Matthijs Moerland, Peter L. J. van Veldhoven, Marieke L. de Kam, Herman Ram, Olivier de Hon, Jelle J. Posthuma, Jacobus Burggraaf, Adam F. Cohen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E374-E386
Number of pages13
JournalThe Lancet Haematology
Volume4
Issue number8
DOIs
Publication statusPublished - Aug 2017

Keywords

  • RECOMBINANT-HUMAN-ERYTHROPOIETIN
  • INCREMENTAL EXERCISE
  • UPTAKE KINETICS
  • DOPING CONTROL
  • TIME
  • INJECTIONS
  • THRESHOLD
  • CAPACITY
  • HUMANS

Cite this

Heuberger, J. A. A. C., Rotmans, J. I., Gal, P., Stuurman, F. E., van 't Westende, J., Post, T. E., Daniels, J. M. A., Moerland, M., van Veldhoven, P. L. J., de Kam, M. L., Ram, H., de Hon, O., Posthuma, J. J., Burggraaf, J., & Cohen, A. F. (2017). Effects of erythropoietin on cycling performance of well trained cyclists: a double-blind, randomised, placebo-controlled trial. The Lancet Haematology , 4(8), E374-E386. https://doi.org/10.1016/S2352-3026(17)30105-9